SSMC is proud to announce the publication of a level 1 study on allogeneic stem cell therapy in the Journal of Translational Medicine.
This study which is a world first in humans, was a Phase 1 / 2 Trial using stem cells from a donor for treatment of osteoarthritis in knees. The principal author for this was SSMC Partner, Dr Donald Kuah and includes two of our previous registrars, Dr Kira James and Dr Thomas Longworth.Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study.
Kuah D, Sivell S, Longworth T, James K, Guermazi A, Cicuttini F, Wang Y, Craig S, Comin G, Robinson D, Wilson J. J Transl Med. 2018 Mar 6;16(1):49. doi: 10.1186/s12967-018-1420-z.